Carnosine augments the efficacy of pulmonary rehabilitation in COPD: insights from a preclinical model
Clinical Science · 10.06.2026 · 140 (6) · 943-960
DOI: 10.1042/cs20260348 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, online erschienen am 15.05.2026. Verfasst von Suleman Abdullah Almerdasi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Respiratory Science and Health, School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC 3083, Australia. Hauptthemen laut MEDLINE: Carnosine, Pulmonary Disease, Chronic Obstructive, Lung. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: DHAC | National Health and Medical Research Council (NHMRC).
Themen: COPD
Abstract (Originalsprache)
Pulmonary rehabilitation (PR) improves exercise tolerance and dyspnoea in chronic obstructive pulmonary disease (COPD) but does not address the elevated cardiovascular disease (CVD) risk. Vascular dysfunction, an early CVD feature, is driven by oxidative stress—a shared pathogenic mechanism in COPD and CVD. Carnosine, a bioactive dipeptide with antioxidant and pH-buffering properties, may enhance muscle performance and protect against vascular injury. The present study sought to determine whether carnosine supplementation combined with exercise training could modify early CVD features in a preclinical COPD model. Male BALB/c mice were exposed to room air or cigarette smoke (CS; 9 cigarettes/day, 5 days/week, 8 weeks) with or without carnosine (1 mg/ml in drinking water) and with or without treadmill exercise training (50% maximal speed; 30 min/day, 5 days/week). After 8 weeks, blood pressure, exercise capacity, resting heart rate, lung inflammation, systemic oxidative stress, aortic endothelial function, and platelet activation were assessed. CS impaired weight gain, reduced exercise capacity, elevated resting heart rate, and induced airway inflammation (P <0.0001). CS also caused severe endothelial dysfunction and platelet activation (P <0.0001). Exercise alone did not reverse these vascular abnormalities. In contrast, carnosine plus exercise restored weight gain, exercise capacity, and heart rate; preserved endothelial function; and prevented platelet adhesion and activation, without altering airway inflammation. Exercise training alone is insufficient to counteract CS-induced vascular injury. Carnosine supplementation provides synergistic vascular protection, highlighting its potential as an adjunct to PR to mitigate oxidative stress-driven CVD risk in COPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Respiratory Science and Health, School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC 3083, Australia.
ORCID-Profile: Suleman Abdullah Almerdasi, Stanley M H Chan, Rana Abdullah Alateeq, Wei Wang, Simone De Luca, Alina Akhtar, Kevin Mou, Huei Jiunn Seow, Steven Bozinovski, Stavros Selemidis, Ross Vlahos
Förderung
- DHAC | National Health and Medical Research Council (NHMRC)
Zitieren
APA
Almerdasi, S. A., Chan, S. M. H., Alateeq, R. A., Wang, W., De Luca, S., Akhtar, A., Mou, K., Seow, H. J., Bozinovski, S., Selemidis, S., & Vlahos, R. (2026). Carnosine augments the efficacy of pulmonary rehabilitation in COPD: insights from a preclinical model. Clinical Science, 140(6), 943-960. https://doi.org/10.1042/cs20260348
Vancouver
Almerdasi SA, Chan SMH, Alateeq RA, Wang W, De Luca S, Akhtar A, et al. Carnosine augments the efficacy of pulmonary rehabilitation in COPD: insights from a preclinical model. Clinical Science. 2026;140(6):943-960. doi:10.1042/cs20260348
BibTeX
@article{Almerdasi2026,
author = {Almerdasi, Suleman Abdullah and Chan, Stanley M H and Alateeq, Rana Abdullah and Wang, Wei and De Luca, Simone and Akhtar, Alina and Mou, Kevin and Seow, Huei Jiunn and Bozinovski, Steven and Selemidis, Stavros and Vlahos, Ross},
title = {Carnosine augments the efficacy of pulmonary rehabilitation in COPD: insights from a preclinical model},
journal = {Clinical Science},
year = {2026},
volume = {140},
number = {6},
pages = {943--960},
doi = {10.1042/cs20260348}
}
EUVIMED